127
Participants
Start Date
September 1, 2021
Primary Completion Date
January 31, 2027
Study Completion Date
March 31, 2027
Intensification of diabetes medication based largely on HbA1c levels
Use of diabetes Rx in controls will be guided largely by HbA1c levels.
Intensification of diabetes medication based on glucose levels
Use of diabetes Rx in the intensive Rx groups will be guided by participants' self-monitored blood glucose levels (SMBG), with management aimed to keep glucose levels within the normal range.
Atlanta VA Medical Center, Decatur
Collaborators (1)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Emory University
OTHER
Abbott Diabetes Care
INDUSTRY
Foundation for Atlanta Veterans Education and Research, Inc.
OTHER